# Efferon JSC clinical trials: 20 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials with Efferon JSC as lead sponsor, 6 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Efferon JSC: 20 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/efferon-jsc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 6
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07889804 | Quality of Life in Patients With Post-Sepsis Syndrome | Efferon JSC | Observational | Not yet recruiting | Sepsis | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889804) |
| May 5, 2026 | NCT07568132 | Efferon LPS Hemoadsorption in in Patients With Thermal Burns | Efferon JSC | Not applicable | Recruiting | Burns | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07568132) |
| April 15, 2026 | NCT07532174 | Efferon LPS Hemoadsorption in Cardiac Surgery Patients | Efferon JSC | Not applicable | Recruiting | Cardiac Disease, Multiple Organ Dysfunction Syndrome | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07532174) |
| February 3, 2026 | NCT07383597 | Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease | Efferon JSC | Not applicable | Not yet recruiting | Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07383597) |
| December 5, 2025 | NCT07267169 | Efferon LPS Hemoadsorption in Patients With Acute Pancreatitis | Efferon JSC | Not applicable | Recruiting | Pancreatitis, Acute | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07267169) |
| December 2, 2025 | NCT07259668 | Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Thermal Burns | Efferon JSC | Observational | Withdrawn | Burns | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07259668) |
| November 25, 2025 | NCT07248930 | Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Thermal Burns | Efferon JSC | Observational | Withdrawn | Burns | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07248930) |
| May 2, 2025 | NCT06955936 | Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction | Efferon JSC | Not applicable | Recruiting | Myocardial Infarction, Cardiogenic Shock | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06955936) |
| October 26, 2024 | NCT06659289 | Hemoperfusion Efferon LPS During Cardiac Surgery Using Cardiopulmonary Bypass | Efferon JSC | Not applicable | Terminated | Cardiac Disease, Multiple Organ Dysfunction Syndrome | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06659289) |
| October 15, 2024 | NCT06640114 | Hemoperfusion With Efferon CT for the Treatment of Patients With Severe Psoriasis | Efferon JSC | Not applicable | Completed | Psoriasis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06640114) |
| September 19, 2024 | NCT06602245 | Clearance of Antibacterial Agents During Hemoperfusion in Patients With Sepsis | Efferon JSC | Observational | Completed | Sepsis, Septic Shock | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06602245) |
| May 8, 2024 | NCT06404424 | Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock | Efferon JSC | Observational | Completed | Sepsis, Septic Shock | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06404424) |
| May 7, 2024 | NCT06402279 | Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19 | Efferon JSC | Observational | Completed | COVID-19 | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06402279) |
| February 3, 2023 | NCT05711901 | Selective Lipopolysaccharide Hemosorption in Maternal Sepsis | Efferon JSC | Not applicable | Completed | Maternal sepsIs | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05711901) |
| February 1, 2023 | NCT05707494 | Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Sepsis | Efferon JSC | Not applicable | Completed | Sepsis, Septic Shock | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05707494) |
| January 23, 2023 | NCT05695001 | Hemoperfusion Efferon СT for the Treatment of Patients With Acute Pancreatitis | Efferon JSC | Observational | Completed | Acute Pancreatitis With Uninfected Necrosis, Unspecified | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05695001) |
| January 23, 2023 | NCT05694988 | Combination of Cytokine Hemosorption and High-volume Hemofiltration in Acute Pancreatitis | Efferon JSC | Not applicable | Completed | Acute Pancreatitis Without Necrosis or Infection | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05694988) |
| November 3, 2021 | NCT05104398 | Hemoperfusion With the Efferon CT Extracorporeal Adsorbers in Patients With Severe Covid-19 | Efferon JSC | Observational | Completed | COVID-19 | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05104398) |
| May 13, 2021 | NCT04884854 | Efferon LPS Hemoperfusion for Treatment of Patients With Septic Shock | Efferon JSC | Observational | Completed | Septic Shock | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04884854) |
| April 1, 2021 | NCT04827407 | Lipopolysaccharide Adsorption At Septic Shock | Efferon JSC | Not applicable | Completed | Septic Shock | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04827407) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 11 |
| Observational | 9 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 11 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Shock, Septic | 6 |
| Sepsis | 6 |
| Pancreatitis | 3 |
| Burns | 3 |
| Heart Diseases | 2 |
| Multiple Organ Failure | 2 |
| COVID-19 | 2 |
| Intraabdominal Infections | 2 |
| Pregnancy Complications, Infectious | 1 |
| Psoriasis | 1 |
| Crohn Disease | 1 |
| Colitis, Ulcerative | 1 |
| Inflammatory Bowel Diseases | 1 |
| Infections | 1 |
| Myocardial Infarction | 1 |
| Shock, Cardiogenic | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Ferry boat companies in the United States](https://specstream.ai/data/businesses/ferry-boat-companies/united-states)
- [Crane services in the United States](https://specstream.ai/data/businesses/crane-services/united-states)
- [Boat and ship manufacturers in the United States](https://specstream.ai/data/businesses/boat-and-ship-manufacturers/united-states)
- [Ambulance services in the United States](https://specstream.ai/data/businesses/ambulance-services/united-states)
- [Tobacco companies in the United States](https://specstream.ai/data/businesses/tobacco-companies/united-states)
- [Retaining wall suppliers in the United States](https://specstream.ai/data/businesses/retaining-wall-suppliers/united-states)
